Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wuhan Dazhong Dental Medical CoHKSE:02651 -6.82%22 EBITDA Margin % is 28.47% as of Dec. 2025, which is 13% below its 10-year median of 32.61. GuruFocus rates HKSE:02651 with a GF Score™ of 22/100. The stock has 4 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Wuhan Dazhong Dental Medical Co ranks better than 91.36% on this metric.
Wuhan Dazhong Dental Medical Co (HKSE:02651) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Wuhan Dazhong Dental Medical Co EBITDA Margin % Related Terms
Wuhan Dazhong Dental Medical Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wuhan Dazhong Dental Medical Co EBITDA Margin % Chart
HKSE:02651 vs HCA, THC, EHC: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Wuhan Dazhong Dental Medical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuhan Dazhong Dental Medical Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wuhan Dazhong Dental Medical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Wuhan Dazhong Dental Medical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wuhan Dazhong Dental Medical Co (HKSE:02651) has a EBITDA Margin % of 28.47% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wuhan Dazhong Dental Medical Co and its competitors. This is 13% below median its historical median of 32.61. Over the past decade, Wuhan Dazhong Dental Medical Co's EBITDA Margin % has ranged from 30.66 to 32.89. According to the industry distribution chart, Wuhan Dazhong Dental Medical Co ranks #58 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 8.6%.
Is Wuhan Dazhong Dental Medical Co's EBITDA Margin % too high?
Wuhan Dazhong Dental Medical Co's current EBITDA Margin % of 28.47% is 13% below median its 10-year median of 32.61. Over the past 10 years, this metric has ranged from a low of 30.66 to a high of 32.89. The Healthcare Providers & Services industry median EBITDA Margin % is 10.09. Wuhan Dazhong Dental Medical Co's value of 28.47% is 182.2% above this industry median. Based on the distribution chart, Wuhan Dazhong Dental Medical Co ranks #58 out of 671 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Wuhan Dazhong Dental Medical Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Wuhan Dazhong Dental Medical Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wuhan Dazhong Dental Medical Co ranks #58 out of 671 companies for EBITDA Margin %. This places Wuhan Dazhong Dental Medical Co in the top 9% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.09. Wuhan Dazhong Dental Medical Co's value of 28.47% is 182.2% above this benchmark. Historically, Wuhan Dazhong Dental Medical Co's own EBITDA Margin % has ranged from 30.66 to 32.89 over the past decade. While the company's 10-year median is 32.61 vs. the industry median of 10.09, Wuhan Dazhong Dental Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.09, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuhan Dazhong Dental Medical Co's current EBITDA Margin % of 28.47% is 182.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wuhan Dazhong Dental Medical Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuhan Dazhong Dental Medical Co's current EBITDA Margin % is 28.47%, which is 13% below median its own 10-year median of 32.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuhan Dazhong Dental Medical Co stock overvalued right now?
Wuhan Dazhong Dental Medical Co (HKSE:02651) has a current EBITDA Margin % of 28.47%. The current EBITDA Margin % is 28.47%, which is 13% below median its 10-year median of 32.61 and 182.2% above the Healthcare Providers & Services industry median of 10.09. Wuhan Dazhong Dental Medical Co's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Wuhan Dazhong Dental Medical Co (HKSE:02651), the current EBITDA Margin % is 28.47% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wuhan Dazhong Dental Medical Co Ltd is a dental services provider in Central China with a focus on Hubei and Hunan provinces, operating an expanding dental service network. The company operates a Partnership Program targeting seasoned medical professionals, to underpin the expansion of its dental service network, maintain the cohesion and stability of its core talent team and facilitate its talent team development, all of which constitute its competitive advantages and make its dental service network an ideal entrepreneurial platform for dentists.
22GF Score
Get the complete analysis for HKSE:02651
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02651 has been successfully added to your 
